| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/06/2008 | US7368427 GLP-1 analogues |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/02/2008 | WO2008051980A2 Methods of reducing phosphate absorption |
| 05/02/2008 | WO2008051502A1 Purine derivatives for the treatment of cystic diseases |
| 05/02/2008 | WO2008051282A2 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | CA2647329A1 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103171 Stable Particular Pharmaceutical Composition of Solifenacin or Salt Thereof |
| 05/01/2008 | US20080103152 7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-3,9-diazabicyclo [3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dichlorobenzyl)amide; renin inhibitor; hypotensive agent, renal and cardial diseases, antidiabetic, antiinflammatory, anxiolitic agent, antidepressant |
| 05/01/2008 | US20080103150 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 05/01/2008 | US20080103147 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/01/2008 | US20080103146 Highly Selective Norepinephrine Reuptake Inhibitors And Methods Of Using The Same |
| 05/01/2008 | US20080103145 Administering racemic reboxetine component |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080102090 Mixture with surfactant; therapy for muscular paralysis; greater intramuscular safety margin; selective action on inhibition of pain-related (nociceptive) nerve cell function |
| 04/30/2008 | EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1915992A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| 04/30/2008 | EP1915147A1 Use of mglur5 (esp. afq056) in gi (esp. gerd) |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP0730657B1 Composition for the in vivo production of therapeutic products |
| 04/30/2008 | DE102006050516A1 New pyrazol-3-one compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful e.g. to treat and/or prophylaxis heart-circulation diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | DE102006050515A1 New substituted dipyridiyl-dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia |
| 04/30/2008 | DE102006050513A1 New substituted dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia |
| 04/30/2008 | DE102006050512A1 New substituted dihydropyrazole- and dihydrotriazole derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases and anemia |
| 04/30/2008 | DE102006050511A1 New substituted dihydrotriazolone compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat or prophylaxis e.g. heart insufficiency, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | DE102006050510A1 New substituted dihydropyrazolthione compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat or prevent e.g. heart insufficiency, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | CN101171249A Method for producing indole derivative having piperidine ring |
| 04/30/2008 | CN101168034A Medicine for treating acute pyelonephritis |
| 04/30/2008 | CN101167997A Chinese medicinal herb oral liquid cold tea preparation for preventing and treating acute and chronic damp-heat virus type nephritic edema |
| 04/30/2008 | CN101167994A Traditional Chinese medicinal composition for treating infantile chronic nephritis |
| 04/30/2008 | CN101167993A Traditional Chinese medicinal preparation for treating acute prostatitis |
| 04/30/2008 | CN101167981A Traditional Chinese medicinal composition for treating infantile acute nephritis |
| 04/30/2008 | CN101167970A Method for preparing gastrodia tuber dispensing granule |
| 04/30/2008 | CN101167955A Chinese medicinal herb cold tea preparation for treating non-gonococcal urethritis |
| 04/30/2008 | CN101167924A Method for producing traditional Chinese medicine preparation of six ingredients with rehmannia |
| 04/30/2008 | CN101167903A Medicinal composition for treating chronic nephritis and its preparing process |
| 04/30/2008 | CN101167892A Traditional Chinese medicinal liquid agent for treating chronic prostatitis |
| 04/30/2008 | CN101167887A Orally-administered matrimony vine single preparation traditional Chinese medicine for treating diabetes and preparation method thereof |
| 04/30/2008 | CN101167863A Proprietary Chinese medicine for treating diabetes and nephrosis and preparing method thereof |
| 04/30/2008 | CN101167862A Traditional Chinese medicine compound preparation for treating diabetes and nephrosis and preparing method thereof |
| 04/30/2008 | CN101167849A Traditional Chinese medicine for treating enuresis caused by fright suddenly |
| 04/30/2008 | CN101167848A Traditional Chinese medicinal formula for treating urinary incontinence |
| 04/30/2008 | CN101167835A Traditional Chinese medicinal composition for treating prostatitis and prostatic hyperplasia |
| 04/30/2008 | CN101167803A Fresh schisandra chinensis extract and its preparation and application |
| 04/30/2008 | CN101167801A Method for preparing scutellaria dispensing granule |
| 04/30/2008 | CN101167729A Application of plant sterol in preparing medicine for treating chronic non-bacterial prostatitis |
| 04/30/2008 | CN101167728A Doxazosin-mesylate controlled-releasing tablet and preparation method thereof |
| 04/30/2008 | CN101167724A Application of medicinal composition containing amlodipine in preparing medicine for treating lower urinary tract disease |
| 04/30/2008 | CN101167720A Application of iridoids compound in preparing medicine for treating benign prostate hyperplasia |
| 04/30/2008 | CN101167707A New use of protocatechuic aldehyde |
| 04/30/2008 | CN101167701A Tamsulosin hydrochloride double-layer osmotic pump controlled-releasing tablet and preparation method thereof |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384844C Xanthine phosphodiesterase V inhibitor polymorphs |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384820C Phosphate prodrugs of fluorooxindoles |
| 04/30/2008 | CN100384441C Pharmaceutical composition for treating acute kidney failure |
| 04/30/2008 | CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 04/30/2008 | CN100384413C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 04/30/2008 | CN100384412C Methods and compositions for inhibiting 5 'alpha'-reductase activity |
| 04/29/2008 | US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
| 04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
| 04/29/2008 | CA2297732C Heterocyclic vinylethers against neurological disorders |
| 04/29/2008 | CA2272711C Method for treating renal failure |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/24/2008 | WO2008047863A1 Sustained release preparation for tissue regeneration therapy |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008047391A1 Nutriceutic composition comprising lactoferrin and proteasic probiotics |
| 04/24/2008 | WO2008046357A1 Aqueous solution containing sodium pyruvate, preparation method and use thereof |
| 04/24/2008 | WO2008046140A1 Improved treatment for benign prostatic hyperplasia |
| 04/24/2008 | WO2007149285A3 Method of improved diuresis in individuals with impaired renal function |
| 04/24/2008 | WO2007144778A3 Herbal compositions for the prevention or treatment of a urinary tract infection |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096925 Analgesics for neuropathy, surgery, nervous system disorders, headaches, arthritis, psoriasis, respiratory system disorders, and gastrointestinal disorders; ethyl 4-phenyl-4-[1-(phenylmethyl)-1H-imidazol-2-yl]-1-piperidinecarboxylate; |
| 04/24/2008 | US20080096923 Determining the severity of retinopathy, neuropathy, and nephropathy; administering 8, 16, or 32 mg one to three times per day of ruboxistaurin, enzastaurin, PKC 412, candesartan cilexetil, fidarestat, lidorestat, pyridoxamine, pegaptanib, or ranibizumab |
| 04/24/2008 | US20080096890 Highly Selective Norepinephrine Reuptake Inhibitors and Methods of Using the Same |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096862 Lactam compounds and pharmaceutical use thereof |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/23/2008 | EP1914232A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 04/23/2008 | EP1913951A1 Method for the extraction of polyphenols and uses thereof |
| 04/23/2008 | EP1913946A1 Therapeutic agent and treatment method for ameliorating uremia |
| 04/23/2008 | EP1913943A1 Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria |
| 04/23/2008 | EP1913940A1 Rhein conjugates, preparation method thereof and their uses in producing medicines for treating diabetic nephrosis, intestinal adhesion and osteoarthritis |